Dyer MJS - Search Results

1

Chronic lymphocytic leukaemia therapy: is less more?

Walter HS, Dyer MJS. Walter HS, et al. Among authors: dyer mjs. Lancet Haematol. 2022 Mar;9(3):e169-e171. doi: 10.1016/S2352-3026(22)00044-8. Lancet Haematol. 2022. PMID: 35240069 No abstract available.

2

Pituitary infiltration in B-cell chronic lymphocytic leukaemia.

Rye AD, Stitson RN, Dyer MJ. Rye AD, et al. Br J Haematol. 2001 Dec;115(4):718. doi: 10.1046/j.1365-2141.2001.03210.x. Br J Haematol. 2001. PMID: 11843801 Free article. No abstract available.

3

Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.

MacFarlane M, Harper N, Snowden RT, Dyer MJ, Barnett GA, Pringle JH, Cohen GM. MacFarlane M, et al. Oncogene. 2002 Oct 3;21(44):6809-18. doi: 10.1038/sj.onc.1205853. Oncogene. 2002. PMID: 12360407

4

TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL-R1 whereas cross-linked agonistic TRAIL-R2 antibodies facilitate signalling via TRAIL-R2.

Natoni A, MacFarlane M, Inoue S, Walewska R, Majid A, Knee D, Stover DR, Dyer MJ, Cohen GM. Natoni A, et al. Br J Haematol. 2007 Nov;139(4):568-77. doi: 10.1111/j.1365-2141.2007.06852.x. Epub 2007 Oct 8. Br J Haematol. 2007. PMID: 17922877 Free article.

5

Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testing.

Bosanquet AG, Richards SM, Wade R, Else M, Matutes E, Dyer MJ, Rassam SM, Durant J, Scadding SM, Raper SL, Dearden CE, Catovsky D. Bosanquet AG, et al. Br J Haematol. 2009 Aug;146(4):384-95. doi: 10.1111/j.1365-2141.2009.07741.x. Epub 2009 Jun 22. Br J Haematol. 2009. PMID: 19552723 Free article.

6

Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells.

Baou M, Kohlhaas SL, Butterworth M, Vogler M, Dinsdale D, Walewska R, Majid A, Eldering E, Dyer MJ, Cohen GM. Baou M, et al. Haematologica. 2010 Sep;95(9):1510-8. doi: 10.3324/haematol.2010.022368. Epub 2010 Apr 7. Haematologica. 2010. PMID: 20378569 Free PMC article.

7

Diminished sensitivity of chronic lymphocytic leukemia cells to ABT-737 and ABT-263 due to albumin binding in blood.

Vogler M, Furdas SD, Jung M, Kuwana T, Dyer MJ, Cohen GM. Vogler M, et al. Clin Cancer Res. 2010 Aug 15;16(16):4217-25. doi: 10.1158/1078-0432.CCR-10-0777. Epub 2010 Jul 2. Clin Cancer Res. 2010. PMID: 20601444 Free PMC article.

8

Defining the prognosis of early stage chronic lymphocytic leukaemia patients.

Pepper C, Majid A, Lin TT, Hewamana S, Pratt G, Walewska R, Gesk S, Siebert R, Wagner S, Kennedy B, Miall F, Davis ZA, Tracy I, Gardiner AC, Brennan P, Hills RK, Dyer MJ, Oscier D, Fegan C. Pepper C, et al. Br J Haematol. 2012 Feb;156(4):499-507. doi: 10.1111/j.1365-2141.2011.08974.x. Epub 2011 Dec 15. Br J Haematol. 2012. PMID: 22171799 Free article.

9

Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia.

Ahearne MJ, Willimott S, Piñon L, Kennedy DB, Miall F, Dyer MJ, Wagner SD. Ahearne MJ, et al. Br J Haematol. 2013 Aug;162(3):360-70. doi: 10.1111/bjh.12401. Epub 2013 May 27. Br J Haematol. 2013. PMID: 23710828 Free article.

10

ABT-199 selectively inhibits BCL2 but not BCL2L1 and efficiently induces apoptosis of chronic lymphocytic leukaemic cells but not platelets.

Vogler M, Dinsdale D, Dyer MJ, Cohen GM. Vogler M, et al. Br J Haematol. 2013 Oct;163(1):139-42. doi: 10.1111/bjh.12457. Epub 2013 Jul 4. Br J Haematol. 2013. PMID: 23826785 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

298 results

Search Page